Either result would be medically important
Metformin shows the strongest potential, supporting its prioritization for targeted studies in people with diabetes who are at high risk of AD, and highlighting the importance of precision medicine in future prevention trials
appetite suppression becomes noticeable Weeks 9-16: Gradual escalation toward 1.7-2.4 mg target dose Months 3-6: Significant weight loss becomes evident
Afamelanotide (Nle-D-Phe--MSH) is MC1R-preferring and used in protoporphyria research because its selectivity limits off-target effects in the central nervous system
It primarily works as an appetite suppressant by stimulating the release of certain brain chemicals, such as norepinephrine, which help reduce hunger and make it easier to follow a calorie-controlled diet
However, the non- or slow biodegradability of pristine MSNs and MONs can lead to long-term retention in vivo, thus inducing possible toxicity risks